Aspen Aerogels Inc vs Nuwellis Inc — how do they compare? Aspen Aerogels Inc trades at $6.14 (market cap $509.55M), while Nuwellis Inc trades at $1.43 (market cap $542.80K). The key difference: Aspen Aerogels Inc is far larger — about 938.7× Nuwellis Inc's market cap, and Aspen Aerogels Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| ASPN | NUWE | |
|---|---|---|
Market Cap | $509.55M | $542.80K |
Sector | Technology | Technology |
52-Week High | $8.82 | $220.50 |
52-Week Low | $2.57 | $1.42 |
Enterprise Value | $482.96M | -$1.27M |
Signals from Pluang's Aura AI — not financial advice
Aspen Aerogels (ASPN) trades at $6.13, down 2.54% today, with a bullish technical signal from moving averages despite mixed oscillators. The company shows improving revenue trends with Q2 2026 results beating expectations and strong Q3 guidance of $65-80 million revenue. However, profitability remains challenged with negative net income margins of -62.45% and consecutive quarterly EPS misses. Analyst sentiment is overwhelmingly positive with 82.61% buy ratings.
The outlook balances strong revenue growth potential in thermal barrier markets against persistent profitability challenges. Investment opportunity lies in the expanding EV thermal barrier business and European market growth, while risks include sustained negative cash flow and competitive pressures in evolving battery technologies.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.
Read more on ASPN →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →